In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...

Treatment About half of the students with attention deficit disorders Disability Services assists are still taking medication, Schrot said. That’s not unusual, said Shapiro. Some adolescents and young ...

Introduction Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and is a persistent pattern of inattention and ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

ADHD symptoms in school-aged children: School-aged children with ADHD may have symptoms like careless mistakes on school work ...

Exercise can have many benefits for your mental health, including a boost in mood, self-esteem, sleep, concentration, memory, ...

Knight Therapeutics Inc. ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PMtm, an extended-release formulation of ...

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules are indicated for the treatment of attention deficit ...

There are several online platforms with medical professionals who are qualified to diagnose you with ADHD. After being ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

Recently, Bollywood actress Alia Bhatt opened up about being diagnosed with ADHD. This brought attention to a prevalent but not much talked about neurological ...

An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023.